Skip to main content

BARCLAYS PLC

Position in PRME — Prime Medicine, Inc.

CIK 312069 LONDON, X0

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$324,933
+$103,004 QoQ
Shares Held
88,058
+38.1% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 186 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. PRME ranks #195 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $324,933 88,058
2026-03-31 $221,929 63,773
2025-12-31 $1,262,476 363,826
2025-09-30 $642,086 115,900
2025-06-30 $283,560 114,802
2025-03-31 $142,133 71,424
2024-12-31 $285,053 97,621
2024-09-30 $327,777 84,697
2024-06-30 $98,194 19,104
2024-03-31 $193,130 27,590
2023-12-31 $480,522 54,235
2023-09-30 $621,435 65,140
2023-06-30 $115,427 7,879
2023-03-31 $65,632 5,336
2022-12-31 $51,782 2,787